Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.46
+0.50001.79%
Pre-market: 28.460.00000.00%04:46 EDT
Volume:45.93M
Turnover:1.30B
Market Cap:161.82B
PE:37.45
High:28.70
Open:27.85
Low:27.64
Close:27.96
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.54
T/O Rate:0.81%
Dividend:1.72
Dividend Rate:6.04%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.90
PE(LYR):20.86

Loading ...

How Investors May Respond To Pfizer (PFE) Prostate Cancer Combo Drug Label Expansion Push

Simply Wall St.
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Healthcare Services (HCSG)

TIPRANKS
·
Jul 23

NYSE Most Active Issues

Dow Jones
·
Jul 23

Pfizer's Talzenna-xtandi Combo Gets FDA Priority Review for Earlier-stage Prostate Cancer

Dow Jones
·
Jul 23

Pfizer's Prostate Cancer Drug Combination Gets FDA Priority Review

Reuters
·
Jul 23

FDA Grants Priority Review for Pfizer’s Talzenna Plus Xtandi for the Treatment of Metastatic Prostate Cancer

THOMSON REUTERS
·
Jul 23

Pfizer - FDA Sets Pdufa Action Date for Talzenna Plus Xtandi in Q4 2026

THOMSON REUTERS
·
Jul 23

Pfizer (PFE) Faces New Patent Lawsuits Over Covid 19 Vaccine Technology

Simply Wall St.
·
Jul 23

Trump Announces Two-Year Zero Tariffs On Imported Generics From Aug. 1, 2026; Then 100% And 200% Hikes

MT Newswires Live
·
Jul 22

Moderately bullish activity in Pfizer with shares up 0.67%

TIPRANKS
·
Jul 22

NYSE Most Active Issues

Dow Jones
·
Jul 21

Cboe data shows mixed options sentiment in Pfizer with shares down 0.7%

TIPRANKS
·
Jul 20

Unusually active option classes on open July 20th

TIPRANKS
·
Jul 20

Pfizer Stock Near Lows But Analysts See Upside Ahead

TIPRANKS
·
Jul 18

Pfizer (PFE) Could Be 16% Undervalued On New FDA Approval In Bladder Cancer

Simply Wall St.
·
Jul 17

NYSE Most Active Issues

Dow Jones
·
Jul 17

Top News Today/canada: Government Enters C$2 Billion Partnership with General Dynamics

Dow Jones
·
Jul 17

Exclusive: Pfizer Temporarily Discontinues Premarin Vaginal Cream in India, Citing Supply Challenges

THOMSON REUTERS
·
Jul 17

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16